Knowledge graph · Cancer
Testicular Neoplasm
subtype
- Identifier
- CI-CAN-00004087
- Entity page
- /cancer/testicular-neoplasm ↗
- Edges
- 487
- Neighbours
- 15 genes28 drugs10 trials
- Drawn
- 53 of 53 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,147Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| Testicular Neoplasm approved for …APPROVED_FORderived3 of 3 | ||||||||
| ← approved for | Etoposidesmall_molecule FDA (US) · approved · 2026-02-13 · Refractory testicular cancer | — | approved | Malignant Testicular Neoplasm | 1 | Regulatory | openfda | graph → |
| ← approved for | Dactinomycinother FDA (US) · approved · 2017-11-09 · adult and pediatric patients with metastatic, nonseminomatous testicular cancer, as part of a multi-phase, combination chemotherapy regimen. | |||||||